| [1] |
Shahid Z, Kalayanamitra R, McClafferty B, et al. COVID-19 and older adults: What we know[J]. J Am Geriatr Soc, 2020, 68(5):926-929.
|
| [2] |
Felsenstein S, Herbert JA, McNamara PS, et al. COVID-19: Immunology and treatment options[J]. Clin Immunol, 2020, 215:108448.
|
| [3] |
Chen X, Zhao B, Qu Y, et al. Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (rnaemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019[J]. Clin Infect Dis, 2020, 71(8):1937-1942.
|
| [4] |
Abdullayev R, Gul F, Bilgili B, et al. Cytokine adsorption in critically ill COVID-19 patients, a case-control study[J]. J Intensive Care Med, 2022, 37(9):1223-1228.
|
| [5] |
Surasit K, Srisawat N. The efficacy of early additional hemoperfusion therapy for severe COVID-19 patients: A prospective cohort study[J]. Blood Purif, 2022, 51(11):879-888.
|
| [6] |
Rampino T, Gregorini M, Perotti L, et al. Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS-CoV2 pneumonia[J]. Blood Purif, 2021, 50(4-5):566-571.
|
| [7] |
Esmaeili Vardanjani A, Ronco C, Rafiei H, et al. Early hemoperfusion for cytokine removal may contribute to prevention of intubation in patients infected with COVID-19[J]. Blood Purif, 2021, 50(2):257-260.
|
| [8] |
Faqihi F, Alharthy A, Alshaya R, et al. Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: A case-report[J]. BMC Cardiovasc Disord, 2020, 20(1):389.
|
| [9] |
国家卫生健康委员会办公厅，国家中医药管理局办公室.关于印发新型冠状病毒肺炎诊疗方案（试行第八版）的通知[EB/OL].（2021-04-14）[2021-04-14].
URL
|
| [10] |
中华医学会肾脏病学分会，中国研究型医院学会肾脏病学专业委员会.特殊血液净化技术应用于重症新型冠状病毒肺炎的专家共识[J].中华内科杂志，2020，59（11）：847-853.
|
| [11] |
Ronco C, Bagshaw SM, Bellomo R, et al. Extracorporeal blood purification and organ support in the critically ill patient during COVID-19 pandemic: Expert review and recommendation[J]. Blood Purif, 2021, 50(1):17-27.
|